Description

▪ Introduction

Dihydroboldenone (DHB), also known as 1-testosterone, is a pharmaceutical-grade anabolic compound commonly studied for its potent anabolic activity and minimal estrogenic conversion. DHB is of particular interest in laboratory settings for its role in supporting anabolic-to-androgenic ratio investigations and its stability in oral tablet form. Adelphi Research offers DHB in a controlled oral delivery format for laboratory and analytical applications.

▪ Product Details

• Active Ingredient: Dihydroboldenone (DHB)

• Dosage Strength: 25 mg per tablet

• Form: Oral tablets

• Brand: Adelphi Research

• Package Size: 30 tablets

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Dihydroboldenone demonstrates high anabolic potential with a relatively low androgenic profile. When administered orally, DHB is absorbed efficiently and undergoes hepatic metabolism. It exhibits minimal interaction with aromatase, reducing the likelihood of estrogen-related activity. The compound has a moderate half-life suitable for once or twice daily administration in laboratory protocols. Its non-estrogenic pathway makes it a subject of interest for studies involving clean anabolic processes without fluid retention.

▪ Usage Recommendations

For laboratory modeling, typical handling includes simulated administration of 25–50 mg per day, divided into one or two doses. Usage periods often span 6–8 weeks in structured analytical cycles. Proper aseptic handling and secure storage conditions are essential for maintaining compound integrity during use.

▪ Disclaimer

This product is intended strictly for laboratory research and analytical use. Not approved for human use or medical treatment. Not suitable for anyone under 18, pregnant or breastfeeding women, or individuals with health conditions. Must be handled according to local regulations and established laboratory safety protocols.